A MULTICENTER, BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFET OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHRITIS. REPORT 2: THE ASSESSMENT OF THE STRUCTURE-MODIFYING EFFECT OF THE DRUG

A MULTICENTER, BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFET OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHRITIS. REPORT 2: THE ASSESSMENT OF THE STRUCTURE-MODIFYING EFFECT OF THE DRUG

Objective. To evaluate the symptom- and structure-modifying effect of Alflutop compared to placebo (PL) in patients with knee osteoarthritis (OA). Material and methods. The study included 90 patients with knee OA (according to the criteria of the Russian Association of Rheumatologists) at the stage...

Full description

Bibliographic Details
Main Authors: L. I. Alekseeva, E. P. Sharapova, E. A. Taskina, N. V. Chichasova, G. R. Imametdinova, N. A. Shostak, N. G. Pravdyuk, L. N. Denisov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2014-06-01
Series:Научно-практическая ревматология
Subjects:
knee osteoarthrosis
blind, randomized, placebo-controlled study
alflutop
placebo.
Online Access:https://rsp.mediar-press.net/rsp/article/view/1921

Internet

https://rsp.mediar-press.net/rsp/article/view/1921

Similar Items